| RECURRENT
VESICOURETHAL STENOSIS AFTER RADICAL PROSTATECTOMY: HOW TO TREAT IT? FRANÇUALDO BARRETO, MARCOS DALL’OGLIO, MIGUEL SROUGI Department of Urology, Paulista School of Medicine, Federal University of Sao Paulo, UNIFESP, Sao Paulo, SP, Brazil ABSTRACT Vesicourethral anastomotic stricture and urinary incontinence are severe complications of radical prostatectomy because they cause great impact in the quality of life. Three patients that presented these complications after prostate radical surgery were assessed retrospectively. To treat the stenosis of the vesicourethral anastomosis an urolume was placed and later on, an artificial sphincter AMS 800 was implanted to treat the resulting urinary incontinence. Key
words: prostatectomy; complications; urethral stricture; stents;
urinary incontinence; prostheses and implants INTRODUCTION Some
complications of radical prostatectomy, especially vesicourethral stricture
and urinary incontinence, have interfered in the patient’s quality
of life, occurring in approximately 4% and 13% of the cases respectively
(1). Vesicourethral stenosis treated with endoscopic uretrotomy is efficient
in 85% of the cases, however in the rest of the cases, stenosis is severe
and recurrent and transurethral procedures are not sufficient to assure
bladder neck patency (1). For those individuals UroLume® is an alternative
for treating the recurrent urethral stenosis and the artificial sphincter
AMS 800 is the better choice to solve the consequent urinary incontinence. CASE REPORT We
present the cases of 3 men that presented recurrent vesicourethral stricture
and urinary retention after radical retropubic prostatectomy. The mean
time of surgical manipulation with urethral catheterization, urethrotomy
and/or cystostomy, in all patients was of 140 days (Table-1). All patients
were accessed through a clinical exam, urethroscopy and urethrography.
When the presence of recurrent urethral stricture was verified, an UroLume®
was indicated after 6 month of the radical prostatectomy (Table-2). After
positioning the urethral stent with the inexorable evolution to urinary
incontinence in all patients, the artificial sphincter AMS 800 was implanted
after 4 months (Table-3). The mean follow-up was 24 months (12 to 40 months). Many
are the determinant factors to vesicourethral stricture such as the anastomotic
rupture, infection, extra-leaking of the urine in the anastomosis site
and previous prostatic surgery. Treatment with urethral dilation is little
effective while endoscopic uretrotomy reaches success around 66 to 85%
(1). For the treatment of severe recurrent stenosis, UroLume® in association
with an artificial sphincter AMS 800 has been a good solution with satisfaction
rates of 88 to 100% (2,3). Generally, complete epithelization of the UroLume®
occurs between 3 to 6 months after its insertion (2), this being the reason
why we recommend the introduction of an artificial sphincter AMS 800 after
4 months of the first procedure and its activation 6 weeks after the implant.
To avoid problems of atrophy and urethral erosion, the pressure on the
sphincter cuff should be between 60-70 cm H2O, however, in those patients
submitted to previous radiotherapy we can suggest a pressure of 51-60
cm H2O (2). CONFLICT OF INTEREST None declared. REFERENCES
___________________ _______________________ |